CaseVu
Precipio’s HemeScreen® Selected as 2022 Best New Product
HemeScreen® Technology and Product Line were recognized by Fisher Healthcare during recent National Sales Meeting [...]
Feb
Precipio Signs Another Major HemeScreen™ Customer
Customer’s initial annual revenue expected at $650K, $2.0M revenue at full capacity NEW HAVEN, CT, [...]
Jan
Precipio Signs Additional Major HemeScreen™ Customer
Customer to begin gradually onboarding panels in Q1-2023, potential $1.2M revenue at full capacity NEW [...]
Dec
Precipio Presents Poster on HemeScreen® Study at Association of Molecular Pathology (AMP) 2022 Annual Conference
Poster presents findings of a study of ~1000 patient samples demonstrating superior accuracy for HemeScreen™ [...]
Nov
Precipio Announces Third Quarter Shareholder Update Call
Conference Call to be held on Monday, November 14th, 2022 at 5:00 PM ET NEW [...]
Nov
Precipio Signs Agreement with Another Major US Healthcare Distributor for HemeScreen™
Adding customer segment exceeding $100M in market potential NEW HAVEN, CT, Globenewswire – (September 15th, [...]
Sep
Sharon Robins Joins Precipio’s Products Division As Senior Director Of Laboratory & Hospital Sales
Precipio continues to build strong team in anticipation of substantial growth in the next 12 [...]
Aug
Precipio Launches New 1-Step Technology For All HemeScreen Assays
New technology enables same day test results by eliminating extra confirmation step NEW HAVEN, CT, [...]
Aug
Toni-Ann Mills Joins Precipio’s Products Division To Lead Channel Partner Training, Learning & Development
Precipio prepares to launch a nationwide HemeScreen sales effort of 250+ sales reps from AmerisourceBergen, [...]
Aug
Precipio Announces Second Quarter Shareholder Update Call
Conference Call to be held on Monday, August 15th, 2022 at 5:00 PM EST NEW [...]
Aug